CADTH Canadian Drug Expert Committee recommendation : indication : diabetes mellitus, type 2. Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.)

CADTH Canadian Drug Expert Committee recommendation indication : diabetes mellitus, type 2. Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.)

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa (ON) : CADTH 2019.
Subjects:
Economic development projects > Cost effectiveness.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820284206719
Description
Physical Description:1 online resource (9 pages)

Similar Items